Meet the specialists: COVID-19 vaccine for cancer patients Q&A

29th January 2021

Missed our free GatewayC LIVE webinar? Watch our recording here.

In this webinar, GatewayC met Professor Robert Duncombe, Director of Pharmacy at The Christie NHS Foundation Trust and Dr Neil Bayman, Consultant Clinical Oncologist and Associate Medical Director at The Christie NHS Foundation Trust.

Our speakers answered key questions from our audience, which included:

  1. Can patients receiving chemotherapy have the vaccine?
  2. Where are patients receiving the vaccine?
  3. Will cancer inpatients receive vaccinations?
  4. Do we advise patients who have had severe taxol reactions to avoid the Pfizer vaccine?
  5. How (as GPs) are we going to know if someone is clinically vulnerable or about to start treatment?

Find out more:

  • Access GatewayC’s full webinar library here
  • Watch this recorded webinar here
  • Access GatewayC’s Managing Physical Effects course here

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: Myeloma and C.R.A.B

Cancer Keys: Myeloma and C.R.A.B

Myeloma and C.R.A.B C.R.A.B is the acronym designed to simplify the most typical clinical manifestations of multiple myeloma. Clinicians should consider the following indicators in a potential myeloma diagnosis: C: Calcium - hypercalcaemia R: Renal – any form of renal...

read more

Related Posts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.